期刊文献+

应用冷冻球囊进行上腔静脉电隔离治疗心房颤动的初步探索 被引量:2

The initial experience of cryoballoon ablation for atrial fibrillation by isolation of superior vena cava
原文传递
导出
摘要 目的探索冷冻消融治疗心房颤动(简称房颤)中应用冷冻球囊进行上腔静脉电隔离的安全性和有效性。方法 4例房颤患者在局麻下接受第二代冷冻球囊冷冻消融手术。在肺静脉隔离后进行上腔静脉冷冻消融达到电隔离。观察术中电隔离相关冷冻参数和膈神经麻痹等主要并发症。术后3个月后进行临床随访观察冷冻消融治疗房颤效果。结果患者均为男性,其中2例为阵发性房颤,2例为持续性房颤。4例患者均在第一次冷冻开始后(36.3±19.3)s达到上腔静脉电隔离,即刻温度(-33.3±5.0)℃,冷冻消融总时间(61.8±26.9)s,最低温度(-40.5±4.4)℃。术中均无血流动力学障碍、穿孔、迷走神经反应、膈神经麻痹和窦性心动过缓等主要并发症发生。术后3个月随访均未见快速型房性心律失常事件发生。结论采用第二代冷冻球囊进行上腔静脉冷冻电隔离治疗房颤的初步经验是安全有效的。 Objective To describe and analyze the key points of applying the cryoballoon ablation to atrial fibrilai ton trigged by superior vena cava (SVC) after the regular cryoballoon-based pulmonary vein isolation. Method A total of four patients were included in this study, who were all diagnosed atrial fibrillation and treated by eryoballoon ablation of the second generation. After all pulmonary vein potentials were isolated, we placed the cryoballoon into the ostium of SVC for ablation.We collected the information in these operations, and followed up all of four patients 3 months later after the operations. Results All of the four patients were males, two of whom were diagnosed paroxysmal atrial fibrillation, another two with continuous atrial fibrillation.The potentials in SVC had achieved isolation in (36.3±19.3) seconds at the first ablation in SVC in all of them. The temperature in the SVC reached (36. 3±19.3)s at the moment of isolation. The total time in SVC ablation were (61.8±26.9)s, and the minimum temperature were (-40.5±4.4)℃. There were no serious complications, such as hemodynamic changes, vasovagal reflex, phrenic nerve paralysis,sinus bradycardia, or perforations. And no atrial tachycardia recurred 3 months after the operations. Conclusion From our experience, it can be safe and effective to apply the eryoballoon ablation in SVC to treat atrial fibrillation.
作者 张浩 刘俊 刘颖 李晓枫 陈会校 韦颖 夏雨 贾玉和 方丕华 张澍 ZHANG Hao;LIU Jun;I.IU Ying;LI Xiao feng;CHENG Hui-xiao;WEI Ying;XIA Yu;JIA Yu-he;FANG Pi-hua;ZHANG Shu(Center for Arrhythmia Diagnosis and Treatment, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037 ,China;The No.2 Central Hospital of Baoding,Baoding 072750,Hebei,China;The No.1 Hospital of Handan,Handan 056002, Hebei, China;The People's Hosptial of Hechi,Hechi 547000,Guangxi, China)
出处 《中国心脏起搏与心电生理杂志》 2018年第1期26-29,共4页 Chinese Journal of Cardiac Pacing and Electrophysiology
关键词 心舡管病学 心房颤动 冷冻球囊 冷冻消融 上腔静脉 Cardiology Atrial fibrillation Cryoballoon ablation Superior vena cava
  • 相关文献

参考文献8

二级参考文献93

  • 1方丕华,马坚,楚建民,姚焰,张奎俊,张澍.冷凝导管消融治疗室上性心动过速的初步体会[J].中华心律失常学杂志,2005,9(1):48-52. 被引量:6
  • 2方丕华,任振芳,马坚,楚建民,姚焰,张奎俊,张澍.经导管冷冻消融治疗房室结折返性心动过速[J].中国心脏起搏与心电生理杂志,2007,21(2):137-140. 被引量:5
  • 3Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic remod- eling after circumferential radiofrequency pulmonary vein ablation: ef- ficacy of an anatomic approach in a large cohort of patients with atrial fibrillation[ J]. Circulation,2001,104:2 539.
  • 4Higuchi K, Yamauchi Y, Hirao K, et al. Superior vena cava as initi- ator of atrial fibrillation : factors related to its arrhythmogenicity [ J ]. Heart Rhythm,2010,7 : 1 186.
  • 5Romano FD, Fenton RA, Dobson JG Jr. The adenosine Ri agonist, phenylisopropyladenosine, reduces high affinity isoproterenol binding to the beta-adrenergic receptor of rat myocardial membranes [ J ]. Sec- ond Messengers Phosphoproteins, 1988,12:29.
  • 6Tebbenjohanns J, Schumacher B, Pfeiffer D,et al. Dose and rate-de- pendent effects of adenosine on atrial action potential duration in hu- mans[J]. J Interv Card Eleetrophysiol, 1997,1:33.
  • 7Kriatselis C, Nedios S, Akrivakis S, et al. Intraproeedural imaging of left atrium and pulmonary veins: a comparison study between rotational angiography and cardiac computed tomography. Pacing Clin Electrophysiol, 2011, 34:315-322.
  • 8Tang M, Kriatselis C, Nedios S, et al. A novel cryoballoon technique for mapping and isolating pulmonary veins: a feasibility and efficacy study. J Cardiovase Eleetrophysiol, 2010, 21:626-631.
  • 9Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace, 2012, 14:528-606.
  • 10Carom AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation- -developed with the special contribution of the European HeartRhythm Association.Europace, 2012, 14:1385-1413.

共引文献56

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部